RECOMBINANT ZIKA VACCINES
The present invention relates to nucleic acid molecules building the basis for immunogenic or vaccine compositions for use in a method of preventing or treating a Zika virus disease in a subject, wherein the at least one nucleic acid molecule comprises at least one recombinant Zika virus antigen, wh...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RAMSAUER, Katrin TAUBER, Erich CSAR, Patrick IRMLER, Angelika SCHRAUF, Sabrina MÜLLNER, Matthias |
| description | The present invention relates to nucleic acid molecules building the basis for immunogenic or vaccine compositions for use in a method of preventing or treating a Zika virus disease in a subject, wherein the at least one nucleic acid molecule comprises at least one recombinant Zika virus antigen, wherein the at least one recombinant Zika virus antigen is encoded by at least one nucleic acid sequence encoding at least one E-protein of a Zika virus or a functional fragment or variant thereof. Further provided are recombinant chimeric viruses encoding and/or comprising selected antigens from a Zika virus. The sequences encoding at least one Zika virus antigen suitable for eliciting an immune response are operably linked to a non-flavivirus derived vector backbone. Further provided are methods for purifying the recombinant chimeric virus particles or the immunogenic composition to provide an immunogenic composition with a low level of process- or product-related impurities. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3393505B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3393505B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3393505B13</originalsourceid><addsrcrecordid>eNrjZJAMcnX293Xy9HP0C1GI8vR2VAhzdHb29HMN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxsaWxqYGpk6GxkQoAQDTpR-P</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RECOMBINANT ZIKA VACCINES</title><source>esp@cenet</source><creator>RAMSAUER, Katrin ; TAUBER, Erich ; CSAR, Patrick ; IRMLER, Angelika ; SCHRAUF, Sabrina ; MÜLLNER, Matthias</creator><creatorcontrib>RAMSAUER, Katrin ; TAUBER, Erich ; CSAR, Patrick ; IRMLER, Angelika ; SCHRAUF, Sabrina ; MÜLLNER, Matthias</creatorcontrib><description>The present invention relates to nucleic acid molecules building the basis for immunogenic or vaccine compositions for use in a method of preventing or treating a Zika virus disease in a subject, wherein the at least one nucleic acid molecule comprises at least one recombinant Zika virus antigen, wherein the at least one recombinant Zika virus antigen is encoded by at least one nucleic acid sequence encoding at least one E-protein of a Zika virus or a functional fragment or variant thereof. Further provided are recombinant chimeric viruses encoding and/or comprising selected antigens from a Zika virus. The sequences encoding at least one Zika virus antigen suitable for eliciting an immune response are operably linked to a non-flavivirus derived vector backbone. Further provided are methods for purifying the recombinant chimeric virus particles or the immunogenic composition to provide an immunogenic composition with a low level of process- or product-related impurities.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210331&DB=EPODOC&CC=EP&NR=3393505B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210331&DB=EPODOC&CC=EP&NR=3393505B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAMSAUER, Katrin</creatorcontrib><creatorcontrib>TAUBER, Erich</creatorcontrib><creatorcontrib>CSAR, Patrick</creatorcontrib><creatorcontrib>IRMLER, Angelika</creatorcontrib><creatorcontrib>SCHRAUF, Sabrina</creatorcontrib><creatorcontrib>MÜLLNER, Matthias</creatorcontrib><title>RECOMBINANT ZIKA VACCINES</title><description>The present invention relates to nucleic acid molecules building the basis for immunogenic or vaccine compositions for use in a method of preventing or treating a Zika virus disease in a subject, wherein the at least one nucleic acid molecule comprises at least one recombinant Zika virus antigen, wherein the at least one recombinant Zika virus antigen is encoded by at least one nucleic acid sequence encoding at least one E-protein of a Zika virus or a functional fragment or variant thereof. Further provided are recombinant chimeric viruses encoding and/or comprising selected antigens from a Zika virus. The sequences encoding at least one Zika virus antigen suitable for eliciting an immune response are operably linked to a non-flavivirus derived vector backbone. Further provided are methods for purifying the recombinant chimeric virus particles or the immunogenic composition to provide an immunogenic composition with a low level of process- or product-related impurities.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAMcnX293Xy9HP0C1GI8vR2VAhzdHb29HMN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxsaWxqYGpk6GxkQoAQDTpR-P</recordid><startdate>20210331</startdate><enddate>20210331</enddate><creator>RAMSAUER, Katrin</creator><creator>TAUBER, Erich</creator><creator>CSAR, Patrick</creator><creator>IRMLER, Angelika</creator><creator>SCHRAUF, Sabrina</creator><creator>MÜLLNER, Matthias</creator><scope>EVB</scope></search><sort><creationdate>20210331</creationdate><title>RECOMBINANT ZIKA VACCINES</title><author>RAMSAUER, Katrin ; TAUBER, Erich ; CSAR, Patrick ; IRMLER, Angelika ; SCHRAUF, Sabrina ; MÜLLNER, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3393505B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>RAMSAUER, Katrin</creatorcontrib><creatorcontrib>TAUBER, Erich</creatorcontrib><creatorcontrib>CSAR, Patrick</creatorcontrib><creatorcontrib>IRMLER, Angelika</creatorcontrib><creatorcontrib>SCHRAUF, Sabrina</creatorcontrib><creatorcontrib>MÜLLNER, Matthias</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAMSAUER, Katrin</au><au>TAUBER, Erich</au><au>CSAR, Patrick</au><au>IRMLER, Angelika</au><au>SCHRAUF, Sabrina</au><au>MÜLLNER, Matthias</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RECOMBINANT ZIKA VACCINES</title><date>2021-03-31</date><risdate>2021</risdate><abstract>The present invention relates to nucleic acid molecules building the basis for immunogenic or vaccine compositions for use in a method of preventing or treating a Zika virus disease in a subject, wherein the at least one nucleic acid molecule comprises at least one recombinant Zika virus antigen, wherein the at least one recombinant Zika virus antigen is encoded by at least one nucleic acid sequence encoding at least one E-protein of a Zika virus or a functional fragment or variant thereof. Further provided are recombinant chimeric viruses encoding and/or comprising selected antigens from a Zika virus. The sequences encoding at least one Zika virus antigen suitable for eliciting an immune response are operably linked to a non-flavivirus derived vector backbone. Further provided are methods for purifying the recombinant chimeric virus particles or the immunogenic composition to provide an immunogenic composition with a low level of process- or product-related impurities.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3393505B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | RECOMBINANT ZIKA VACCINES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T18%3A46%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAMSAUER,%20Katrin&rft.date=2021-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3393505B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |